Literature DB >> 31967517

Gene signatures of breast cancer development and the potential for novel targeted treatments.

Charu Kothari1,2, Caroline Diorio2,3, Francine Durocher1,2.   

Abstract

Entities:  

Keywords:  TNBC; breast cancer progression; epigenetics; gene signature; hereditary breast cancer; target therapy

Mesh：

Substances：

Year:  2020        PMID： 31967517     DOI： 10.2217/pgs-2019-0158

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN： 1462-2416            Impact factor:   2.533


× No keyword cloud information.
  3 in total

Review 1.  BARD1 mystery: tumor suppressors are cancer susceptibility genes.

Authors:  Yousef M Hawsawi; Anwar Shams; Abdulrahman Theyab; Wed A Abdali; Nahed A Hussien; Hanan E Alatwi; Othman R Alzahrani; Atif Abdulwahab A Oyouni; Ahmad O Babalghith; Mousa Alreshidi
Journal:  BMC Cancer       Date:  2022-06-01       Impact factor: 4.638

2.  Nuclear Morphological Characteristics in Breast Cancer: Correlation with Hormone Receptor and Human Epidermal Growth Factor Receptor 2.

Authors:  Jiayu Li; Yehan Zhou; Yunzhu Li; Yang Liu
Journal:  Anal Cell Pathol (Amst)       Date:  2021-11-12       Impact factor: 2.916

Review 3.  BARD1 and Breast Cancer: The Possibility of Creating Screening Tests and New Preventive and Therapeutic Pathways for Predisposed Women.

Authors:  Marcin Śniadecki; Michał Brzeziński; Katarzyna Darecka; Dagmara Klasa-Mazurkiewicz; Patryk Poniewierza; Marta Krzeszowiec; Natalia Kmieć; Dariusz Wydra
Journal:  Genes (Basel)       Date:  2020-10-24       Impact factor: 4.096
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.